<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141555">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01258179</url>
  </required_header>
  <id_info>
    <org_study_id>11.2009</org_study_id>
    <nct_id>NCT01258179</nct_id>
  </id_info>
  <brief_title>Peri-operative Expression Analysis of Pancreatic Stone Protein in a Surgical Study Population</brief_title>
  <official_title>Peri-operative Expression Analysis of Pancreatic Stone Protein and Pancreatitis-associated Protein in a Surgical Study Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the peri-operative expression of pancreatic stone
      protein and pancreatitis-associated protein in surgical patients following major abdominal
      surgery by blood samples.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosed Infections according to the Systemic Inflammatory Response System (SIRS) Criteria of the german interdisciplinary Association of Intensive and Emergency Medicine</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit (ICU) stay in days</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay in days</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications according to the &quot;Clavien-Dindo Classification&quot; System</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital costs</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparisons to other known infectious parameters: c-reactive protein (CRP), procalcitonin (PCT), Interleukin 6 (IL-6), Tumor Necrosis Factor Alpha (TNF-alpha), Leucocytes</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacteriaemia in the blood</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelets in the blood</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Patients Undergoing Major Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>Sepsis Group</arm_group_label>
    <description>Patients suffering from sepsis in the postoperative course after major abdominal surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Patients without suffering sepsis during postoperative follow up after major abdominal surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Analysis of PSP and PAP from venous blood samples</intervention_name>
    <description>to analyse the peri-operative expression of pancreatic stone protein in surgical patients following major abdominal surgery</description>
    <arm_group_label>Sepsis Group</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Venous blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major abdominal surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria: - &gt;= 18 years

          -  abdominal major surgery

          -  need for post-operative ICU care

        Exclusion criteria: - &lt;18 years

        - patients who do not agree the written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian E Oberkofler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian E Oberkofler, MD</last_name>
    <phone>+41 (0)44 255 11 11</phone>
    <email>christian.oberkofler@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rolf Graf, Prof. PhD</last_name>
    <phone>+41 (0)44 255 2071</phone>
    <email>rolf.graf@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Visceral and Transplantation Surgery</name>
      <address>
        <city>Zurich</city>
        <state>CH/ZÃ¼rich</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian E Oberkofler, MD</last_name>
      <phone>+41- (0)44 255 1111</phone>
      <email>christian.oberkofler@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Rolf Graf, Prof. PhD</last_name>
      <phone>+41- (0)44 255 2071</phone>
      <email>rolf.graf@usz.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Christian E Oberkofler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 3, 2014</lastchanged_date>
  <firstreceived_date>December 7, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Christian E. Oberkofler</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
